Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team

What are you looking for?

  • Conference Roundup
  • Contact Lenses
  • Diagnostics
  • Glaucoma
  • Myopia
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Retina
  • Spotlight Series
The evolving role of the optometrist in nonsurgical cataract management
Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team
Home > SH-based artificial tears show superior symptom relief in dry eye disease study
  • Ocular Surface Disease

SH-based artificial tears show superior symptom relief in dry eye disease study

Kelsey Moroz

A recent study evaluated the short-term efficacy of carboxymethylcellulose (CMC), polyethylene glycol (PEG) 400, and sodium hyaluronate (SH)-based artificial tears in stabilizing tear film and improving symptoms in patients with moderate dry eye disease.

The prospective, double-masked study included 100 patients divided into 5 groups based on the artificial tear used.

All formulations were found to significantly improve noninvasive tear breakup time. However, the groups had no significant difference in tear meniscus height or bulbar redness. Patients reported better symptom relief with SH-based lubricants compared to 0.5% and 1% CMC-based drops and a combination SH-PEG-PG formulation.

The researchers concluded that a single drop of CMC, SH, or PEG-based artificial tears enhances tear film stability, although no significant differences were observed in their short-term effects.

Reference
Maity M, Allay MB, Ali MH, et al. Effect of different artificial tears on tear film parameters in dry eye disease. Optom Vis Sci. 2024;doi: 10.1097/OPX.0000000000002206. Epub ahead of print. PMID: 39729080.

Share

Related Content

  • Ocular Surface Disease

Perceived stress may precede worsening dry eye symptoms in young adults

  • Ocular Surface Disease

Post-menopausal women show more severe evaporative dry eye disease

  • Ocular Surface Disease

Dry eye diagnostic practices remain inconsistent worldwide, survey finds

  • Ocular Surface Disease

Spotlight on VEVYE®

  • Ocular Surface Disease

Intervening early in dry eye disease: reducing patient cost and disease burden

  • Ocular Surface Disease

Consensus guidance helps identify misdiagnosed demodex blepharitis

Share

Advisory Board

Kaleb Abbott, OD, MS, FAAO

Clark Chang, OD

Jessica Haynes, OD, FAAO, FORS, Dipl ABO

Monica Kalia, OD

Cecelia Koetting, OD, FAAO, DipABO

Roya Attar, OD, MBA, DHA, FAAO

Hardeep Kataria, OD, FAAO

Marc R. Bloomenstein, OD, FAAO

Elise Kramer, OD

See All
Optometry 360

Optometry 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

© 2026 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophthalmology360 Icon